Joincare Pharmaceutical Group Industry Co Ltd (600380):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Joincare Pharmaceutical Group Industry Co Ltd (600380) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3494
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Joincare Pharmaceutical Group Industry Co Ltd (Joincare Pharma) is a manufacturer and supplier of pharmaceutical products. The company offers healthcare products, bulk prescription products, active pharmaceutical ingredients, OTC products, detection reagents, and food additives. Its healthcare products include beauty essence, menocare essence, blood replenishing supplement, tea and lozenge, leaf extracts, and others. Joincare Pharma’s prescription products comprise valsartan capsules, amlodipine besylate capsules, isosorbide mononitrate tablets, ceftriaxone sodium, voriconazole, cefuroxime sodium, urofollitropin, menotrophin and chorionic gonadotrophin for injection. The company’s OTC products include anti-viral granules, hydrochloride capsules, bifidobacterium capsules, potassium citrate capsules and tablets, silver sulfadiazine cream, compound bornyl salicylate ointment and dexamethasone acetate adhesive tablets, among others. It exports its products to the US, Australia, Singapore, Malaysia, Taiwan, Marco and Hong Kong. The company operates its subsidiaries throughout China. Joincare Pharma is headquartered in Shenzhen, China.

Joincare Pharmaceutical Group Industry Co Ltd (600380) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Joincare Pharmaceutical Group Industry Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Cynvenio Biosystems Raises USD25.5 Million in Series B Equity Financing 11
Partnerships 12
Livzon Pharma Plans to Form Joint Venture in Zhuhai City 12
Equity Offering 13
JoinCare Pharma Plans to Raise USD290 Million in Publlic Offering 13
Livzon Pharma Raises USD230.4 Million in Private Placement of Shares 14
Joincare Pharma to Raise Funds in Private Placement of Shares 15
Cynvenio Biosystems Raises USD10 Million in Private Placement of Series B Preferred Shares 16
Debt Offering 17
Joincare Pharma Raises USD58.5 Million in First Tranche of Public Offering of 4.88% Bonds 17
Joincare Pharma to Raise USD319.7 Million in Public Offering of Notes 18
Acquisition 19
Livzon Pharma to Sell 15% Stake in Livzon Group Xinbeijiang Pharma to Zhuhai Zhong Hui Yuan for USD10.5 Million 19
Livzon Biologics to Acquire Remaining 51% Stake in Livzon MabPharm from Livzon Pharma for USD48.7 Million 20
Livzon Biologics to Acquire 49% Stake in Livzon MabPharm from Joincare Pharma for USD45.7 Million 21
Livzon Pharma to Sell its Pharma Firm for USD661 Million 22
Joincare Pharmaceutical Group Industry Co Ltd – Key Competitors 23
Joincare Pharmaceutical Group Industry Co Ltd – Key Employees 24
Joincare Pharmaceutical Group Industry Co Ltd – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Joincare Pharmaceutical Group Industry Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Joincare Pharmaceutical Group Industry Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cynvenio Biosystems Raises USD25.5 Million in Series B Equity Financing 11
Livzon Pharma Plans to Form Joint Venture in Zhuhai City 12
JoinCare Pharma Plans to Raise USD290 Million in Publlic Offering 13
Livzon Pharma Raises USD230.4 Million in Private Placement of Shares 14
Joincare Pharma to Raise Funds in Private Placement of Shares 15
Cynvenio Biosystems Raises USD10 Million in Private Placement of Series B Preferred Shares 16
Joincare Pharma Raises USD58.5 Million in First Tranche of Public Offering of 4.88% Bonds 17
Joincare Pharma to Raise USD319.7 Million in Public Offering of Notes 18
Livzon Pharma to Sell 15% Stake in Livzon Group Xinbeijiang Pharma to Zhuhai Zhong Hui Yuan for USD10.5 Million 19
Livzon Biologics to Acquire Remaining 51% Stake in Livzon MabPharm from Livzon Pharma for USD48.7 Million 20
Livzon Biologics to Acquire 49% Stake in Livzon MabPharm from Joincare Pharma for USD45.7 Million 21
Livzon Pharma to Sell its Pharma Firm for USD661 Million 22
Joincare Pharmaceutical Group Industry Co Ltd, Key Competitors 23
Joincare Pharmaceutical Group Industry Co Ltd, Key Employees 24
Joincare Pharmaceutical Group Industry Co Ltd, Subsidiaries 25

List of Figures
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Joincare Pharmaceutical Group Industry Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Joincare Pharmaceutical Group Industry Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Joincare Pharmaceutical Group Industry Co Ltd (600380):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kbc Bank Ireland Plc:企業の戦略・SWOT・財務分析
    Kbc Bank Ireland Plc - Strategy, SWOT and Corporate Finance Report Summary Kbc Bank Ireland Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Baxter International Inc.:企業の戦略・SWOT・財務情報
    Baxter International Inc. - Strategy, SWOT and Corporate Finance Report Summary Baxter International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Bisalloy Steel Group Ltd:企業の戦略・SWOT・財務情報
    Bisalloy Steel Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Bisalloy Steel Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Dermapharm AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Dermapharm AG (Dermapharm) is a pharmaceutical company that offers dermatological and allergy medicines. The company offers products for allergies, disinfection and wound treatment, skin and hair care, corticoids, minerals, osteoporosis, fungal infections, vaginal thrush, other preparations, …
  • Aker Solutions ASA (AKSO):企業の財務・戦略的SWOT分析
    Aker Solutions ASA (AKSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Xylem Inc (XYL)-エネルギー分野:企業M&A・提携分析
    Summary Xylem Inc. (Xylem) is a water technology company that designs, manufactures, and service engineered technologies for water industry. The company’s products portfolio includes testing equipment; filtration, disinfection and biological treatment equipment; controls and systems; and water and w …
  • 84 Lumber Company:企業の戦略・SWOT・財務分析
    84 Lumber Company - Strategy, SWOT and Corporate Finance Report Summary 84 Lumber Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Old Mutual Plc:戦略・SWOT・企業財務分析
    Old Mutual Plc - Strategy, SWOT and Corporate Finance Report Summary Old Mutual Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Erasmus MC-製薬・医療分野:企業M&A・提携分析
    Summary Erasmus MC (Erasmus) is a medical institute that offers patient care, research and educational services. The institute offers graduate and doctoral programs in health sciences, biomedical sciences, molecular medicine and cardiovascular sciences. It conducts research in the areas of biochemis …
  • Newpark Resources Inc (NR):石油・ガス:M&Aディール及び事業提携情報
    Summary Newpark Resources Inc (Newpark) offers fluid systems and services to oil and gas industry. The company offers drilling fluid products, solutions and services supporting directional, horizontal and deep water drilling projects. It grinds barite, which is used as a raw material in drilling flu …
  • LHC Group Inc (LHCG):企業の財務・戦略的SWOT分析
    Summary LHC Group Inc (LHC Group) is an in-home healthcare service provider. The center offers home health, hospice, personal care services and facility-based services. It covers a range of healthcare needs for patients and families dealing with illness, injury, and chronic conditions. LHC Group pro …
  • Kingspan Group Plc:企業のM&A・事業提携・投資動向
    Kingspan Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kingspan Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Purdue Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Purdue Pharma Inc (Purdue Pharma Canada), a subsidiary of Purdue Pharma LP is a research-based pharmaceutical company that offers services such as development, manufacturing and commercialization of medicines for patients and healthcare professionals. The company portfolio of products includ …
  • Nuance Communications, Inc.:企業の戦略・SWOT・財務情報
    Nuance Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nuance Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Vattenfall AB:企業の戦略的SWOT分析
    Vattenfall AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Gildan Activewear Inc.:企業の戦略・SWOT・財務情報
    Gildan Activewear Inc. - Strategy, SWOT and Corporate Finance Report Summary Gildan Activewear Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Clarient Inc-医療機器分野:企業M&A・提携分析
    Summary Clarient Inc (Clarient) is a cancer diagnostic laboratory services provider that provides comprehensive cancer–diagnostic laboratory services. The company provides oncology testing and other diagnostics services. Clarient offers detailed information to characterize and assess cancer for accu …
  • Bharti Infratel Ltd
    Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report Summary Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Integrated Sensing Systems Inc:企業の製品パイプライン分析2018
    Summary Integrated Sensing Systems Inc (ISSYS) is a technology company that provides scientific sensing applications. The company provides business units such as medical, fluidic, foundry services, nanogetters, and others. designs and manufactures measurement instruments and sensors. Its medical uni …
  • Thales Deutschland GmbH:企業の戦略・SWOT・財務情報
    Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report Summary Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆